Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.

Jason Fangusaro
Arzu Onar-Thomas
Tina Young Poussaint
Shengjie Wu
Azra H Ligon
Neal Lindeman
Anuradha Banerjee
Roger J Packer, George Washington University
Lindsay B Kilburn
Stewart Goldman
Ian F Pollack
Ibrahim Qaddoumi
Regina I Jakacki
Paul G Fisher
Girish Dhall
Patricia Baxter
Susan G Kreissman
Clinton F Stewart
David T W Jones
Stefan M Pfister
Gilbert Vezina, George Washington University
Jessica S Stern
Ashok Panigrahy
Zoltan Patay
Benita Tamrazi
Jeremy Y Jones
Sofia S Haque
David S Enterline
Soonmee Cha
Michael J Fisher
Laurence Austin Doyle
Malcolm Smith
Ira J Dunkel
Maryam Fouladi

Epub ahead of print

Abstract